Antibody Drug
- All
- News
- Videos
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Antibodies, Vaccines Less Effective Against Coronavirus Variants: Study
COVID-19 antibody-based drugs and vaccines developed so far may become less effective as new variants of the novel coronavirus spread widely, according to a new study.
-
UK Scientists Trial Instant Immunity Antibody Drug Treatment For Covid
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
This Japanese Company Is Working On World's First Drug To Grow New Teeth
The company is set to conduct clinical trials on healthy adults in July 2024 to verify the safety of its new drug.
-
Cancer Disappears From Every Patient's Body In Drug Trial In US: Report
A group of 12 rectal cancer patients showed no signs of a tumour after taking an antibody drug for six months, according to a surprise finding from an ongoing medical trial in the US that experts termed optimistic.
-
No Anti-Covid Drug, Antibody Cocktail Therapy In Revised Covid Guidelines
According to the revised guidelines, there is no evidence of injectable steroids in those who doesn't require oxygen supplementation or in continuation, after discharge, because that can lead to a risk of secondary infection like mucormycosis.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
Antibody Drug Cuts Deaths From Some Severe Covid Patients: Study
A cocktail of synthetic antibodies reduces deaths among severe Covid patients who are unable to mount a strong immune response, results from a major clinical trial showed Wednesday.
-
"Symptoms Gone In A Day": Doctor On Antibody Cocktail To 40 In Hyderabad
As many as 40 Covid patients have taken a single-dose drug cocktail of monoclonal antibodies at Hyderabad's Asian Institute of Gastroenterology. "In 24 hours, they recovered from clinical symptoms like fever, malaise etc," said top doctor.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Antibody Cocktail Used In Covid Treatment Gets Emergency Use Approval
Drug firm Roche India on Wednesday said it has received Emergency Use Authorisation (EUA) from the Central Drugs Standards Control Organisation (CDSCO) for Roche's investigational antibody cocktail used in the treatment of COVID-19.
-
Antibodies, Vaccines Less Effective Against Coronavirus Variants: Study
COVID-19 antibody-based drugs and vaccines developed so far may become less effective as new variants of the novel coronavirus spread widely, according to a new study.
-
UK Scientists Trial Instant Immunity Antibody Drug Treatment For Covid
Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19.
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
